| Product NDC: | 16714-361 |
| Proprietary Name: | Famotidine |
| Non Proprietary Name: | Famotidine |
| Active Ingredient(s): | 20 mg/1 & nbsp; Famotidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16714-361 |
| Labeler Name: | NorthStar RxLLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078916 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090701 |
| Package NDC: | 16714-361-03 |
| Package Description: | 90 TABLET in 1 BOTTLE (16714-361-03) |
| NDC Code | 16714-361-03 |
| Proprietary Name | Famotidine |
| Package Description | 90 TABLET in 1 BOTTLE (16714-361-03) |
| Product NDC | 16714-361 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Famotidine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | ANDA |
| Labeler Name | NorthStar RxLLC |
| Substance Name | FAMOTIDINE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |